Focal Therapy for Prostate Cancer: Is It Being Oversold?
Medscape,
In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped.
In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped.
Summary EDAP TMS reported Q2 2023 revenues of $15.52 million, a 0.9% YoY growth that missed estimates.